All Stories

  1. Exploring the SARS-Cov-2 Main Protease (Mpro) and RdRp Targets by Updating Current Structure-based Drug Design Utilizing Co-crystals to Combat COVID-19
  2. Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking
  3. Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
  4. Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID-19
  5. Exploring the Abnormal Signal Transduction Mediated Internet Addiction and Gaming Disorders
  6. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
  7. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment
  8. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors
  9. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking
  10. Phyto-chlorophyllin prevents alloxan-induced toxicity
  11. A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-Behnken Design
  12. In Silico Factorial Screening and Optimization of Chitosan Based Gel for Urapidil Loaded Microparticle using Reduced Factorial Design
  13. Current Development on Chitosan-based Antimicrobial Drug Formulations for the Wound Healing
  14. Abnormal Signal Transduction via Over-expression of Pim-1 Regulated Senescence, Cell Cycle, Apoptosis and Metastatic Invasion: Novel Anticancer Targets and Their Potent Inhibitors from Marine Sources
  15. To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing co-crystallized Ligand to Combat HCV
  16. Computer aided chitosan anchor nanoparticles
  17. QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis
  18. Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design
  19. Zika virus. Zika Viral Targets. Synthetic and Natural Sourced Inhibitors.
  20. Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads
  21. Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction
  22. Current Drug Design Strategies for Fighting Against Swine Influenza
  23. Recent Advances in Ligand and Structure Based Screening of Potent Quorum Sensing Inhibitors Against Antibiotic Resistance Induced Bacterial Virulence
  24. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors
  25. In silico evaluation of 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one compounds: an insight into design of less toxic anticancer drugs
  26. QSAR and structure based design of selective GABA-A receptor antagonists
  27. QSAR and Drug Design
  28. QSAR and pharmacophore modeling of indole-based C-3 pyridone compounds as HCV NS5B polymerase inhibitors utilizing computed molecular descriptors
  29. QSAR modeling of 4-anilinofuro[2,3-b]quinolines: an approach to anticancer drug design
  30. Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique
  31. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers
  32. Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors
  33. Importance of Kier-Hall Topological Indices in the QSAR of Anticancer Drug Design
  34. Design of fast dissolving amlodipine besylate tablet formulations
  35. Activity Prediction of Some Nontested Anticancer Compounds Using GA-Based PLS Regression Models
  36. In silicodesign of potent EGFR kinase inhibitors using combinatorial libraries
  37. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors
  38. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
  39. Anticancer Activity of Selected Phenolic Compounds: QSAR Studies Using Ridge Regression and Neural Networks
  40. QSAR Analysis of BABQ compounds via calculated molecular descriptors